Substance use & recovery

Writing a Medical Necessity Appeal That Holds Up

Save

Insurers deny addiction and mental-health care as 'not medically necessary' more often than most other services. An appeal is your formal rebuttal. This walks through what a medical necessity appeal letter contains, how to anchor it to the clinical criteria your insurer already uses, how federal parity law strengthens the argument, and the internal-then-external timeline that decides who has the final say.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What is a medical necessity appeal?

A medical necessity appeal is a written request asking a health plan to overturn a denial it issued on the grounds that a service was not medically necessary. It is not a complaint letter. It is a structured argument that matches your clinical situation to the plan's own definition of medical necessity and to the criteria the plan uses to decide placement. Substance-use and mental-health care draw these denials more often than most medical care, which is part of why the appeal process exists.

Medical necessity is the plan's standard for whether it will pay: care that is clinically appropriate for the diagnosis, delivered at the right level of intensity, and consistent with accepted standards of practice. A denial asserts your care failed one of those tests. Your appeal shows, point by point, that it did not.

What a strong appeal letter contains

A medical necessity appeal letter works best when it is short, specific, and organized around the denial itself. Open by naming the patient, the plan, the claim or authorization number, the exact service denied, and the reason the insurer gave. Then rebut that reason with clinical facts and records. A reviewer reading dozens of these should be able to find your argument in the first paragraph.

The pieces that belong in it:

  • The denial, quoted back. The date, the service, and the plan's stated reason, word for word, so there is no ambiguity about what you are appealing.
  • The clinical story. Diagnosis, history, what was tried before, and why the denied level of care is the appropriate one — drawn from the record, not from memory.
  • The standard it meets. The recognized criteria the care satisfies, named explicitly rather than gestured at.
  • The records that prove it. Assessment notes, the treating clinician's letter of support, and prior treatment history.
  • The ask. One clear sentence: reverse the denial and authorize the service.

Keep the treating clinician's letter of support attached rather than paraphrased. A denial that pits the plan's reviewer against your own physician's judgment is one you want documented in writing.

How do you anchor the letter to a recognized standard?

The most persuasive appeals do not argue that care is necessary in the abstract; they show it meets a standard the insurer already recognizes. For addiction treatment, that benchmark is usually the ASAM Criteria, the framework that matches a person to a level of care based on assessed severity across several dimensions. Citing the specific criteria your assessment met turns "we believe this is necessary" into "this meets the yardstick you use." Naming the ASAM Criteria as the placement standard, with the dimension your assessment scored, gives the reviewer a concrete peg to grant.

Where a medication is involved, the national treatment guideline is a second anchor. For opioid use disorder, the guideline recommends treating the disorder with methadone or buprenorphine rather than with withdrawal management alone, and it holds that medication should not be arbitrarily time-limited 1. If a denial cuts a stay short or refuses to continue medication, quoting that guideline puts the insurer's decision at odds with the recognized standard of care.

Arguing that the care meets the standard of care

When a denial claims a treatment is not evidence-based, the counter is to show it is the accepted standard of care. Medications for opioid use disorder are the clearest example: they are an evidence-based standard, and treating the disorder with methadone or buprenorphine is not "substituting one addiction for another" — at therapeutic doses these medications reduce cravings and withdrawal without producing a high 2. An appeal can state this plainly and cite it.

There are three FDA-approved medications for opioid use disorder — methadone, buprenorphine, and naltrexone — described in a federal consensus reference 3. If a denial rests on an outdated view that medication is a crutch, the mat vs abstinence-only question is already settled in the guidelines, and the letter can point the reviewer there. The same logic separates two decisions people often blur: a plan may authorize medical detox, a short and distinct service, while denying the treatment that should follow it. Those are two denials, and each is contested on its own terms — do not let one approval be mistaken for coverage of the whole course of care.

Using your parity rights as leverage

Federal parity law is one of the strongest tools in an appeal. The Mental Health Parity and Addiction Equity Act generally requires a plan that covers mental-health and substance-use benefits to apply no more restrictive financial requirements or treatment limits to them than it applies to comparable medical and surgical care 4. If your plan authorizes a comparable medical hospitalization readily but denies residential addiction care, or imposes review hurdles it does not use elsewhere, that disparity is itself a parity argument worth naming.

The limit is worth stating accurately so your letter is credible: parity does not by itself require a plan to cover substance-use treatment at all 4. It governs how a plan treats a benefit it already offers, not whether the benefit exists. So the parity argument bites when your plan covers SUD care but applies a harsher standard to it — which is the common situation. Parity is about equal treatment of a benefit you already have, not a guarantee that the benefit exists.

Internal appeal, then external review

Most plans run appeals in two stages, and the order matters. First comes the internal appeal, decided by the insurer itself, usually within a deadline printed on the denial — often short when care is ongoing. If the internal appeal fails, you generally have the right to an independent external review whose decision the plan must honor. Knowing the internal appeal and external review sequence keeps you from missing the window that decides everything.

  • Read the denial for the deadline. It is often measured in days, and an expedited appeal exists when a delay would jeopardize health.
  • Request the plan's criteria. You can ask for the specific medical-necessity criteria the reviewer applied; appealing a coverage denial is far easier once you can see the yardstick you are being measured against.
  • Escalate if the internal appeal fails. The external review is a fresh, independent set of eyes, and a state insurance regulator can be a further route.

Appealing a denied treatment claim is a process with steps and deadlines, not a single letter — but the letter is the spine of it.

Common denial reasons, and how to answer them

Denials cluster around a handful of reasons, and each has a standard counter. Matching your rebuttal to the exact reason the plan gave — rather than making a general case for treatment — is what separates an appeal that gets read from one that gets filed and forgotten. Find your denial's language in the letter, then answer that specific claim.

Denial reasonWhat the appeal shows
"Not medically necessary at this level"The assessment met the recognized placement criteria for that level; a lower level was tried or would be unsafe
"Could be treated at a lower level of care"Specific clinical facts — safety, prior failed attempts, co-occurring conditions — that make the lower level inappropriate
"Length of stay exceeded"The guideline does not support an arbitrary time limit, and the record shows continued need 1
"Experimental or not evidence-based"The treatment is an accepted standard of care backed by federal guidance 3

Each row is a claim you support with a record, not an adjective. The denial letter tells you which row you are in, and the appeal answers that row directly.

Common questions

No. Most appeals are written by the patient, a family member, or the treatment provider's billing staff. What matters is not legal polish but a clear match between the denial reason and the clinical records that answer it. A letter of support from the treating clinician often carries more weight than legal language. Legal help becomes useful mainly if an external review also fails.

The deadline is printed on the denial and is often measured in days rather than weeks, especially for care that is ongoing. Many plans also offer an expedited or urgent appeal when a delay would jeopardize health, which is decided far faster. The single most common way appeals fail is missing the window, so the deadline is the first thing to read.

A denied internal appeal is usually not the end. For most plans you then have the right to an external review by an independent third party, and its decision the plan must honor. State insurance regulators can be a further route. The external review is a fresh set of eyes not employed by the insurer, which is why it sometimes reverses a denial the internal process upheld.

Often, yes, with your authorization. Many programs have utilization-review or billing staff who handle appeals routinely and know the plan's criteria. Even when you write the letter yourself, the treating clinician's assessment notes and letter of support are the evidence that makes it persuasive, so involving the provider is worthwhile either way.

No. The federal parity law requires a plan that covers substance-use care to apply no stricter limits to it than to comparable medical care, but it does not by itself force a plan to cover addiction treatment in the first place. It is a powerful argument when your plan offers the benefit but treats it more harshly than medical care, which is the usual scenario in a denial.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

If things feel heavy, a person is available anytime — call or text 988.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Do not let an appeal delay urgent care

  • A withdrawal seizure, or confusion, sweating, fever, and a racing heart during alcohol or benzodiazepine withdrawal — signs of delirium tremens that need emergency care regardless of coverage
  • An opioid overdose: slow or stopped breathing, blue or gray lips and fingertips, or a person who cannot be woken
  • Thoughts of suicide while waiting on a coverage decision or after a denial
  • A denial that pauses care for someone whose clinician has said an interruption is unsafe

Call 911 for a suspected overdose or a withdrawal seizure. For thoughts of suicide, call or text 988. Emergency care does not wait on an insurer's approval, and a hospital must stabilize an emergency regardless of coverage. SAMHSA's National Helpline gives free, confidential treatment referrals 24/7, and FindTreatment.gov lists licensed programs.

This article is general information about the insurance-appeal process, not legal or medical advice. Plan rules, definitions of medical necessity, and appeal deadlines vary by insurer and by state. Decisions about care should be made with a licensed clinician, and questions about a specific denial are best directed to the plan and, where needed, a state insurance regulator.

References

  1. 1.American Society of Addiction Medicine (2020). The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder — 2020 Focused Update. American Society of Addiction Medicine (ASAM). linkUsed for the claim that the guideline recommends treating opioid use disorder with methadone or buprenorphine rather than withdrawal management alone, and that medication should not be arbitrarily time-limited — the basis for contesting a length-of-stay or medication-continuation denial.
  2. 2.National Institute on Drug Abuse (2024). Medications for Opioid Use Disorder. National Institute on Drug Abuse (NIDA), NIH. linkUsed for the claim that medications for opioid use disorder are an evidence-based standard of care and that they are not 'substituting one addiction for another,' since at therapeutic doses they reduce cravings and withdrawal without producing a high.
  3. 3.Substance Abuse and Mental Health Services Administration (2021). TIP 63: Medications for Opioid Use Disorder — Full Document. SAMHSA Treatment Improvement Protocol 63. linkUsed for the claim that the three FDA-approved medications for opioid use disorder are methadone, buprenorphine, and naltrexone, described in a federal consensus reference an appeal can cite as accepted standard of care.
  4. 4.Centers for Medicare & Medicaid Services (2024). Mental Health Parity and Addiction Equity Act (MHPAEA). Centers for Medicare & Medicaid Services (CMS). linkUsed for the claim that MHPAEA generally bars plans covering mental-health/substance-use benefits from imposing more restrictive financial requirements or treatment limits than for comparable medical care, but does not itself require a plan to cover substance-use treatment.

4 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy